No Picture
Trading Ideas

Nasdaq warns of market manipulation during coronavirus volatility

Financial firms should be on the lookout for potential market manipulation as the spike in volatility and volumes driven by coronavirus concerns could embolden traders with bad intentions looking to “hide amongst the noise,” Nasdaq Inc said on Friday. The U.S. stock market is on course for its worst month in three decades as fears of the severity of the pandemic have led to a massive sell-off, with the S&P 500 losing nearly 30%, or more than $8 trillion, in value since hitting a record closing high on Feb. 19. As volumes spike, so do the number of …read more […]

No Picture
Trading Ideas

3 Top Defensive Plays for the Bear Market

We’re in a bear market now, with the major indexes down nearly 30% from their most recent peak. The S&P 500 has fallen from 3,386 – it’s high point on February 19 – down to 2,437 as of this writing. The fall hasn’t been smooth; stocks have bounced down a steep slope marked by sharp spike and deep troughs.So, the markets are stormy, and the bears are here, but a savvy stock trader should always remember what a bear does when the weather changes: it hunkers down, and hibernates for the long haul. It’s a defensive strategy, and investors should …read more […]

No Picture
Trading Ideas

3 5G Stocks That Are Poised to Rebound

By now, the coronavirus isn’t news. We all know what’s going on, even if we’re not quarantined or languishing in lockdown. COVID-19, spreading in a global pandemic, has struck markets with a hammer blow, and the main indexes remain down at least 29% from their February highs.Investors are confused. We’ve seen bouts of panic selling, along with sporadic purchase activity by insiders, and there has been no consistency in stocks’ reactions to the news cycle.Still, there are some sectors that are likely to keep bring returns for investors long-term. Among the chief of these are tech stocks, especially those connected …read more […]

No Picture
Trading Ideas

CureVac IPO: Coronavirus Vaccine Firm Going Public?

A CureVac IPO is running through investors’ minds. CureVac’s current project is a coronavirus vaccine. So, investors want to know how they can get in on the action.
But there isn’t any CureVac stock yet. The company is still privately held. However, with CureVac’s newest discovery, the biotech firm has great potential for investors. Here’s what we know…
CureVac IPO: The Business

Dr. Ingmar Hoerr founded CureVac in 2000. It’s a leading biotech company based in Tübingen, Germany. The company uses messenger RNA (mRNA) technology. It helps develop cancer therapies and the treatment of rare diseases. CureVac started working on its first mRNA-based …read more […]